Genprex Stock Performance
| GNPX Stock | USD 2.30 0.54 19.01% |
The company retains a Market Volatility (i.e., Beta) of -1.26, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Genprex are expected to decrease by larger amounts. On the other hand, during market turmoil, Genprex is expected to outperform it. At this point, Genprex has a negative expected return of -1.29%. Please make sure to check out Genprex's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Genprex performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Genprex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (14.44) | Five Day Return (16.78) | Year To Date Return 35.75 | Ten Year Return (99.97) | All Time Return (99.97) |
Last Split Factor 1:50 | Last Split Date 2025-10-21 |
1 | Why Genprex Inc. stock attracts wealthy investors - July 2025 Reactions Capital Efficient Trading Techniques - newser.com | 11/20/2025 |
2 | Data from Genprexs Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer | 11/24/2025 |
3 | Acquisition by Pearson Robert W. of 101156 shares of Genprex at 2.15 subject to Rule 16b-3 | 11/28/2025 |
4 | Genprex, Inc. Stock Opinions on Recent Preclinical Data Release - Quiver Quantitative | 12/03/2025 |
5 | Cracker Barrel Old Country Store Shares Unloaded Rep. Tim Moore | 12/05/2025 |
6 | Acquisition by Wilson William R Jr. of 9000 shares of Genprex subject to Rule 16b-3 | 12/22/2025 |
7 | Genprex Provides Clinical Update on Diabetes Gene Therapy Program | 01/07/2026 |
8 | Aug Spikes How does Genprex Inc score in quality rankings - Fed Meeting High Accuracy Investment Signals - baoquankhu1.vn | 01/15/2026 |
| Begin Period Cash Flow | 6.7 M | |
| Total Cashflows From Investing Activities | 1166.00 |
Genprex Relative Risk vs. Return Landscape
If you would invest 664.00 in Genprex on October 29, 2025 and sell it today you would lose (421.00) from holding Genprex or give up 63.4% of portfolio value over 90 days. Genprex is currently does not generate positive expected returns and assumes 8.5332% risk (volatility on return distribution) over the 90 days horizon. In different words, 76% of stocks are less volatile than Genprex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Genprex Target Price Odds to finish over Current Price
The tendency of Genprex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.30 | 90 days | 2.30 | about 73.64 |
Based on a normal probability distribution, the odds of Genprex to move above the current price in 90 days from now is about 73.64 (This Genprex probability density function shows the probability of Genprex Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Genprex has a beta of -1.26. This usually indicates as returns on its benchmark rise, returns on holding Genprex are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Genprex is expected to outperform its benchmark. Additionally Genprex has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Genprex Price Density |
| Price |
Predictive Modules for Genprex
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genprex. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Genprex Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genprex is not an exception. The market had few large corrections towards the Genprex's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genprex, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genprex within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.92 | |
β | Beta against Dow Jones | -1.26 | |
σ | Overall volatility | 2.53 | |
Ir | Information ratio | -0.23 |
Genprex Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genprex for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genprex can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Genprex generated a negative expected return over the last 90 days | |
| Genprex has high historical volatility and very poor performance | |
| Genprex has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (21.11 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genprex currently holds about 25.52 M in cash with (17.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53. | |
| Genprex has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Aug Spikes How does Genprex Inc score in quality rankings - Fed Meeting High Accuracy Investment Signals - baoquankhu1.vn |
Genprex Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genprex Stock often depends not only on the future outlook of the current and potential Genprex's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genprex's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 80.1 K | |
| Cash And Short Term Investments | 1.6 M |
Genprex Fundamentals Growth
Genprex Stock prices reflect investors' perceptions of the future prospects and financial health of Genprex, and Genprex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genprex Stock performance.
| Return On Equity | -6.12 | ||||
| Return On Asset | -2.07 | ||||
| Current Valuation | 4.41 M | ||||
| Shares Outstanding | 1.63 M | ||||
| Price To Earning | (1.09) X | ||||
| Price To Book | 7.19 X | ||||
| EBITDA | (21.1 M) | ||||
| Net Income | (21.11 M) | ||||
| Cash And Equivalents | 25.52 M | ||||
| Cash Per Share | 0.53 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 1.11 % | ||||
| Current Ratio | 10.71 X | ||||
| Book Value Per Share | 2.10 X | ||||
| Cash Flow From Operations | (17.15 M) | ||||
| Earnings Per Share | 42.50 X | ||||
| Market Capitalization | 6.76 M | ||||
| Total Asset | 4.12 M | ||||
| Retained Earnings | (154.8 M) | ||||
| Working Capital | (426.7 K) | ||||
| Current Asset | 964.42 K | ||||
| Current Liabilities | 587.7 K | ||||
About Genprex Performance
Evaluating Genprex's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Genprex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genprex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 43.4 K | 28.3 K | |
| Return On Tangible Assets | (4.61) | (4.38) | |
| Return On Capital Employed | (15.03) | (14.28) | |
| Return On Assets | (5.89) | (5.59) | |
| Return On Equity | (14.98) | (14.24) |
Things to note about Genprex performance evaluation
Checking the ongoing alerts about Genprex for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genprex help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genprex generated a negative expected return over the last 90 days | |
| Genprex has high historical volatility and very poor performance | |
| Genprex has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (21.11 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genprex currently holds about 25.52 M in cash with (17.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53. | |
| Genprex has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Aug Spikes How does Genprex Inc score in quality rankings - Fed Meeting High Accuracy Investment Signals - baoquankhu1.vn |
- Analyzing Genprex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genprex's stock is overvalued or undervalued compared to its peers.
- Examining Genprex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genprex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genprex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genprex's stock. These opinions can provide insight into Genprex's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.